Latest filing published 11 May 2018 for Valeant Pharmaceuticals International, Inc., €2.2M. Read the official filing
All filings by Joseph Papa on record concern Valeant Pharmaceuticals International, Inc. Over a trading history stretching from 2 May 2016 to 3 May 2018, the count stands at 5 filings.
No open-market sale appears; the market trades are 2 purchases worth €3.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise. So far in 2018, the count stands at 1 purchase and no sales.
The newest entry dates from 11 May 2018: an option exercise of €2.2M, in Valeant Pharmaceuticals International, Inc. The clock since the last published purchase (14 March 2018) now reads 3,143 days. Between a trade and the moment it shows up on SEDI, the median delay is 8 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations